Celon Labs

Celon Laboratories is a specialty-focused biopharmaceutical company headquartered in Hyderabad, India, with core competencies in Oncology and Critical Care. The company develops innovative, non-infringing, cost-effective formulations in niche therapy areas, serving both Indian and international markets across 50+ countries. Celon's R&D capabilities span Novel Drug Delivery Systems including Microspheres, Liposomal, and Nanoparticulate formulations. Its product portfolio includes oncology-focused offerings under the Vivilon brand and critical care products under the Revilon brand, with notable achievements including launching India's first indigenous bone marrow transplant range. The company is backed by UK-based investors including the CDC Group, DPI, and EBRD.